By Marcus Chen, MS, Clinical Science Writer. Medically reviewed by Dr. Lila Carter, MD, MPH, Board-Certified Obesity Medicine.
A step-by-step walkthrough for people who want to get through injection day without bouncing between six browser tabs. Each step stands on its own.
This article is part of the FormBlends ultimate guide to compounded tirzepatide and the GLP-1 Long-Term & Maintenance hub.
The phone call that prompted this guide
Last October, a woman named Rachel in Scottsdale called her prescriber's after-hours line at 9:40 p.m. She'd been on compounded tirzepatide for six weeks, titrated up to 5 mg. Her pharmacy had refilled the vial at a new concentration (10 mg/mL instead of the previous 5 mg/mL), and she'd drawn the same number of units she always drew. She realized the mistake 20 seconds after injecting: she'd given herself double the prescribed dose. She was fine, but she spent the next eight hours nauseated on her bathroom floor, and her prescriber spent 15 minutes on the phone walking her through what to watch for.
"I just didn't re-read the label," Rachel told her clinician the next morning. "It looked like the same vial."
That story, or some version of it, plays out more often than it should. The fix isn't complicated. It's a five-step habit.
What to have on the counter before you start
Gather everything in one place: your current pharmacy vial (label facing you), a U-100 insulin syringe in the right volume (typically 0.3 mL or 0.5 mL for compounded GLP-1 dosing), an alcohol prep pad, a sharps container, the prescribed dose written on paper, and your prescriber's contact number.
Read the label twice. Two numbers matter: the concentration in mg/mL and the total fill volume. The concentration drives the math. The fill volume tells you how many doses are in the vial.
Verify the medication name, the patient name, the expiration date, and the storage condition before each injection. If anything looks wrong, do not inject. Call the pharmacy.
Step 1: Confirm what you're actually doing
Right medication. Right patient. Right dose in milligrams (as written on the prescription). Right injection day on the schedule.
Get medications from a trusted source
FormBlends sources through 503A compounding pharmacies with third-party purity testing on every batch.
Start Free Assessment →This is boring. It's also the step people skip, and skipping it is the most common root cause of dosing errors. A practical trick: write the prescribed dose on a small sticker and put it on the vial cap at the first fill. That way the number is visible every time the cap comes off.
The figures and protocols cited in this guide trace back to peer-reviewed publications and FDA prescribing information for brand-name products. Compounded formulations are not FDA-reviewed, and practical guidance about compounded products reflects the standard clinical protocol for the underlying active ingredient.
Step 2: Do the actual math
Take the prescribed dose in milligrams. Divide by the concentration in mg/mL. The result is the volume in mL to draw. Multiply by 100 to convert to units on a U-100 syringe.
Write it down. Do not trust your memory, especially if multiple family members are on different doses or if you're managing more than one medication.
If the calculation lands on a fractional unit (say, 12.5 units), confirm with your prescriber before rounding. Don't improvise rounding decisions on your own. That's how Rachel's story starts.
Step 3: The 30-second check that catches half the mistakes
Read the dose back to yourself out loud. Or read it to a family member. Or call the pharmacy and read it to a tech.
This takes thirty seconds. In self-administered injection protocols, a simple read-back catches roughly half of the errors that would otherwise reach the syringe. It's the highest-leverage step in the entire process. Nothing else comes close for effort-to-payoff ratio.
Step 4: The injection itself
Clean the injection site with the alcohol prep pad. Wait for it to dry. Pinch a fold of skin if needed (depends on injection-site fat depth). Insert the needle at 90 degrees, push the plunger smoothly, count to five with the needle still in place, then withdraw and drop the syringe into the sharps container immediately.
Rotate sites across weeks: abdomen, front of thigh, back of upper arm. Stay at least two inches away from the navel. Do not inject through clothing.
Related reading in this cluster
- Can glp 1 cause appendicitis?
- Zepbound Before And After: Complete Guide
- Faint After Donating Blood: Complete Guide
Step 5: Write it down, then review it monthly
Record the date, the dose in milligrams, the units drawn, the injection site, and any unusual symptoms. A notes app works. A paper log works. Anything searchable works.
Here's the thing: a single injection tells you almost nothing. A log reviewed monthly with your prescriber tells you a lot. Trends in tolerability, patterns of side effects relative to dose changes, gaps in adherence. The signal is in the sequence, not the snapshot.
Related reading from adjacent topics
Three mistakes that keep showing up
Using last month's unit count with this month's concentration. Pharmacies sometimes refill at a different concentration. The unit count changes even though the milligram dose doesn't. Always re-read the label. Always.
Injecting the same spot every week. It's comfortable. It's also how you develop nodules and lipohypertrophy, which then affect absorption. Rotate.
Leaving the vial on the kitchen counter. If the medication has been outside the recommended temperature range, call the pharmacy before injecting. A vial that sat in a hot car for four hours is not necessarily ruined, but you shouldn't guess.
When to stop and call someone
Seek immediate care for: severe abdominal pain (especially radiating to the back, which can signal pancreatitis), persistent vomiting that prevents fluid intake, jaundice or right-upper-quadrant pain (possible gallbladder disease), signs of an allergic reaction (rash, facial or throat swelling, difficulty breathing), severe dehydration, or thoughts of self-harm.
Call your prescriber within 24 to 48 hours for: nausea that hasn't resolved after two weeks at a stable dose, new vision changes, ongoing constipation despite adequate hydration and fiber, or any new symptom you can't explain.
For non-urgent questions about dosing, timing, or routine side effects, schedule a follow-up. Don't self-adjust. The dose-escalation schedule is protocol-driven, and changes should be made with your prescriber, not between you and a Reddit thread.
Putting the trial numbers in perspective
Trial averages compress enormous variance into a single number. SURMOUNT-1 reported substantial differences in response within the same dose arm, which is the normal pattern across GLP-1 trials. Reading the published distribution behind the average is more useful than reading the average alone.
Real-world cohorts add even more variance, mostly from adherence and lifestyle differences. The strongest predictor of long-term outcome across the GLP-1 class is months on therapy at or near the maintenance dose. Nutrition, resistance training, hydration, and sleep amplify what the medication does. But time on therapy trumps everything else.
My honest editorial take: most people underestimate how much the boring consistency stuff (logging, rotating sites, re-reading labels, showing up for follow-ups) matters relative to which specific compound they're on. The medication is the engine. The habits are the fuel line.
Frequently asked questions
Is this something I should discuss with a clinician?
Yes. Any question that affects how a prescription medication is dosed, stored, or administered is worth raising with your prescriber. This article is general education, not a substitute for individualized clinical guidance.
Where does this fit into my overall plan?
Most decisions in GLP-1 care become clearer in the context of your full picture: indication, comorbidities, lifestyle inputs, goals. This article gives the general framework. The plan gets built with a prescriber who knows your history.
What if my situation is more complicated than what's described here?
Articles describe the general case. If your case feels unusual, ask for a longer visit with your prescriber, sometimes with additional specialty input. That's the right move.
How often will this guidance change?
The underlying mechanisms and foundational trial data are stable. Coverage, pricing, and regulatory specifics shift more often. Confirm anything time-sensitive with a current source.
Is compounded tirzepatide FDA-approved?
No. Compounded tirzepatide is not an FDA-approved drug. The FDA does not review compounded medications for safety, effectiveness, or quality prior to dispensing. Compounded medications are dispensed under personalized prescriptions through state-licensed pharmacies when a prescriber determines a personalized formulation is clinically appropriate.
Do I need a special syringe?
A standard U-100 insulin syringe works. The volume (0.3 mL or 0.5 mL) depends on how much liquid your dose requires. Your pharmacy or prescriber can confirm the right size.
Can I skip the read-back step if I've been doing this for months?
You can. But the people who make concentration-change errors are almost always experienced patients, not first-timers. Familiarity breeds exactly the kind of comfort that leads to skipping the label.
Continue the series
Important Safety Information
This article is for educational purposes only and is not medical advice. Compounded tirzepatide and compounded semaglutide are not FDA-approved drugs. The FDA does not review compounded medications for safety, effectiveness, or quality before they are sold. Compounded medications should only be used when a licensed prescriber determines a personalized formulation is clinically appropriate. Do not start, stop, or modify any prescription medication without speaking with a licensed healthcare provider. If you experience symptoms of a serious reaction, including severe abdominal pain, signs of pancreatitis, vision changes, persistent vomiting, signs of an allergic reaction, or thoughts of self-harm, seek emergency care immediately.
FormBlends sells only compounded semaglutide and compounded tirzepatide through licensed U.S. pharmacies after a telehealth evaluation by an independent prescriber. Eligibility, pricing, and formulation are determined on a case-by-case basis.
About this article
Written by Marcus Chen, MS (Clinical Science Writer). Medically reviewed by Dr. Lila Carter, MD, MPH (Board-Certified Obesity Medicine). FormBlends content is reviewed by licensed U.S. clinicians prior to publication. The clinical decisions described above are general education only and should not replace individualized advice from your own healthcare provider.